Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
Dédée F. Murrell(Sutherland Hospital), Victoria P. Werth(Philadelphia VA Medical Center), Animesh A. Sinha(University at Buffalo, State University of New York), Daniel Mimouni(Rabin Medical Center), N Hunzelmann, Russell P. Hall(Duke University), David Sirois(California University of Pennsylvania), Sarah Dick(California University of Pennsylvania), Yasuo Kitajima(Tohoku University), Pilar Iranzo(Universitat de Barcelona), Michael Hertl(Philipps University of Marburg), María A. Barnadas(Universitat Autònoma de Barcelona), Neil J. Korman(University Hospitals of Cleveland), Linda K. Martin(The University of Sydney), Takashi Hashimoto(Kurume University), Luis A. Díaz(Memorial Sloan Kettering Cancer Center), P. Joly(Hôpital Charles-Nicolle), David Fivenson, A. R. Ahmed(New England Baptist Hospital), Giuseppe Cianchini(Istituto Dermopatico dell'Immacolata), Masayuki Amagai(RIKEN Center for Integrative Medical Sciences), Amit G. Pandya(The University of Texas Southwestern Medical Center), Luca Borradori(University Dermatology), Marcel F. Jonkman(University Medical Center Groningen), Detlef Zillikens(University of Lübeck), Hiroshi Shimizu(Hokkaido University), David Rubenstein(University of North Carolina at Chapel Hill), Karen Harman(University Hospitals of Leicester NHS Trust), Jean‐Claude Bystryn(Columbia University Irving Medical Center), Aimee Payne(University of Pennsylvania)
Cited by 586
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
|New England Journal of Medicine|2020|2.9k